Amondys 45 Injection
Product Images NDC 60923-227

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amondys 45 (NDC 60923-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarepta Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amo01 0003 01

Amo01 0003 01
Chemical structure of casimersen, the active ingredient in AMONDYS 45 50 mg/mL intravenous injection. This diagram shows the detailed molecular structure of the oligonucleotide compound used in the drug product by Sarepta Therapeutics, Inc.*
FDA Label Image

Amo01 0003 02

FDA Label Image

Amo01 0003 03

Amo01 0003 03
Packaging label for AMONDYS 45 (casimersen) Injection 100 mg/2 mL (50 mg/mL) for intravenous infusion after dilution. The single-dose vial label includes storage instructions to refrigerate at 2°C-8°C and avoid freezing, dilution requirements with 0.9% Sodium Chloride Injection, and a note to use a 0.2 micron in-line filter during infusion. It also lists inactive ingredients and the manufacturer, Sarepta Therapeutics, Inc., Cambridge, MA.*
FDA Label Image

Amo01 0003 04

Amo01 0003 04
Label for AMONDYS 45 (casimersen) Injection, 100 mg/2 mL (50 mg/mL), single-dose vial. The label indicates the product is prescription only and is manufactured for Sarepta Therapeutics, Inc., Cambridge, MA. It includes an NDC number and barcode, as well as spaces for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.